Shalini Shenoy, MD
Washington University School of Medicine · Washington University School of Medicine (in St. Louis)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Shalini Shenoy, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03128996 · Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant DisordersWashington University School of Medicine · recruiting · Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders · principal investigator
- Ph2NCT01005576 · Reduced Intensity Transplant Conditioning Regimen for Severe ThalassemiaWashington University School of Medicine · completed · Severe Thalassemia · principal investigator
- Ph1/Ph2NCT00920972 · Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant DiseasesWashington University School of Medicine · recruiting · Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.